These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17705263)

  • 1. Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level.
    Liaw YF
    Hepatology; 2007 Sep; 46(3):947; author reply 947-9. PubMed ID: 17705263
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
    Dai CY; Chuang WL; Huang JF; Yu ML
    Hepatology; 2009 Feb; 49(2):704-5; author reply 705-6. PubMed ID: 19177587
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B.
    Mohamadnejad M; Malekzadeh R
    N Engl J Med; 2004 Jun; 350(26):2719-20. PubMed ID: 15218580
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
    Allain JP; Sarkodie F; Candotti D; Opare-Sem O
    Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
    Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
    Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of HBe antigen and alanine aminotransferase levels in hepatitis B virus DNA positive patients.
    Imtiaz F; Abbas Z; Moatter T
    J Coll Physicians Surg Pak; 2005 Feb; 15(2):103-4. PubMed ID: 15730837
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific considerations in the design of hepatitis B virus clinical studies in the far East.
    Yuen MF; Lai CL
    Methods Mol Med; 2004; 96():457-64. PubMed ID: 14762287
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.
    Tseng TC; Liu CJ; Hsieh SC; Chen PJ; Lai MY; Chen DS; Kao JH
    Dig Liver Dis; 2009 Apr; 41(4):322-3. PubMed ID: 18848814
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
    Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
    Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prediction of fulminant hepatitis in severe acute hepatitis B].
    Michitaka K; Onji M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():269-73. PubMed ID: 15453328
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
    Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
    Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. e-antigen-negative chronic hepatitis B in Bangladesh.
    Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectivity of hepatitis B].
    Gerken G
    Dtsch Med Wochenschr; 1996 Apr; 121(14):459. PubMed ID: 8665822
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between HIV and hepatitis B.
    Bonacini M
    AIDS; 1997 Nov; 11(14):1789-90. PubMed ID: 9386822
    [No Abstract]   [Full Text] [Related]  

  • 16. Changing landscape of antiviral resistance management in chronic hepatitis B.
    Nguyen T; Locarnini S; Desmond P
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progresses in the molecular diagnosis of hepatitis B viral infection].
    Panait M; Oprişan G; Codiţă I
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):5-12. PubMed ID: 19241991
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of infectivity of carriers of hepatitis B antigen using viral DNA detection].
    Gerlich WH; Heermann KH; Uy A; Zyzik E; Thomssen R
    Offentl Gesundheitswes; 1987; 49(8-9):380-4. PubMed ID: 2958735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.